Journal of Cancer Research and Therapeutics Close
 

Figure 1: Summary of drug combinations with 2 DG SKBr3 cells incubated with the indicated agent for 24 h. 2DG was added and incubation continued for 4 h. Cytotoxicity was evaluated using the MTT assay. 2DG at 0.5 mM was used for all combinations except cisplatin (1 mM 2DG). The concentrations of the chemotherapeutic agents were doxorubicin (dox), 1 ýM; cisplatin (CP), 20 ýM; 5-fluorouracil (5-FU), 20 ýM; Herceptin (Her); cyclophosphamide (cyclo), 2 mM

Figure 1: Summary of drug combinations with 2 DG SKBr3 cells incubated with the indicated agent for 24 h. 2DG was added and incubation continued for 4 h. Cytotoxicity was evaluated using the MTT assay. 2DG at 0.5 mM was used for all combinations except cisplatin (1 mM 2DG). The concentrations of the chemotherapeutic agents were doxorubicin (dox), 1 ýM; cisplatin (CP), 20 ýM; 5-fluorouracil (5-FU), 20 ýM; Herceptin (Her); cyclophosphamide (cyclo), 2 mM